American College of Rheumatology (ACR)

ACR Releases Position Statement on Telemedicine




Newswise — ATLANTA - The American College of Rheumatology (ACR) has released an official position statement supporting the role of telemedicine as a tool with the potential to increase access and improve care for patients with rheumatic diseases. It also highlights the significant barriers and opportunities presented to patients and rheumatology professionals.  

“The SARS-CoV-2 (COVID-19) pandemic has presented both challenges and opportunities to rheumatology professionals who have rapidly adopted telemedicine in routine practice,” said Chris Phillips, MD one, of the statement’s lead authors and member of the ACR’s Committee on Rheumatologic Care (CORC). “As providers plan for rheumatology care post-COVID, taking into consideration rheumatology workforce shortages and geographically distant patients, it is apparent that telemedicine could help rheumatology providers improve care models for their patients if the long-term economic and regulatory landscape remains favorable.” 

The statement contains eight positions, including ACR support for: 

  • The role of telemedicine as a tool with the potential to increase access and improve care for patients with rheumatic diseases, but it should NOT replace essential face-to-face assessments conducted at medically appropriate intervals. 
  • The need for continued parity of reimbursement for in-office visits, audio-visual visits and audio-only visits, both by CMS and by commercial payers, after the declared COVID-19 public health emergency (PHE) has ended, if telemedicine services abide by the following four principles: 
  • (1) The provider-patient relationship should include both in-person and telemedicine services in accordance with the American Medical Association (AMA) Code of Medical Ethics as it pertains to the patient-provider relationship, and specifically the ethical practice in telemedicine.
  • (2) Patients should have a choice of provider for telemedicine services, as is required for all medical services. 
  • (3) The standards and scope of care provided remotely via telemedicine services should be consistent with related in-person services. The limitations of the relevant technologies should be recognized, and appropriate steps taken to mitigate these limitations. 
  • (4) The provision of telemedicine services must be properly documented. 
  • Telemedicine platforms that provide an efficient mechanism to obtain informed consent for delivery of telemedicine services. 
  • Appropriate protocols to protect the security and integrity of patient information, while balancing the need for access to telehealth services. 
  • Proposals which would facilitate interstate practice of telemedicine. 
  • Outcomes-based research regarding telemedicine use in the practice of rheumatology. 

The statement also includes ACR opposition to the following: 

  • Geographical restrictions on telemedicine practice including rural designation requirements, and, supports the ongoing ability of patients to access telemedicine services from their home after the PHE has ended. 
  • Payer policies which dictate use of specified telemedicine platforms, use telemedicine services to construct restrictive networks, or which use telemedicine as a means to divert patients to their “preferred” providers. 

Telemedicine is the provision of health care services and education over a distance through the use of telecommunications technology. During the COVID-19 pandemic, many federal, state and reimbursement barriers were waived allowing rheumatology practices to provide telemedicine services (including audio-only and audio-visual visits) as part of ongoing efforts to prevent exposure to and spread of COVID-19 among providers, office staff and vulnerable patients. 

Prior efforts on the part of rheumatology providers to expand use of telemedicine had been hampered by a multitude of factors, including federal and state regulations, reimbursement issues, and practical issues pertaining to the provision of care. 

 “While telemedicine should not replace many of the hands-on skills and in-office assessments rheumatology professionals provide, patients in all areas of the U.S. should have access to telemedicine, regardless of location, and the services should be included in all subscriber benefits and insurance plans,” said Aruni Jayatilleke, MD one of the statement’s lead authors and member of CORC. “Additionally, rheumatology professionals should be reimbursed equitably for telemedicine services and have access to a streamlined state medical license process.” 

Despite promising preliminary evidence regarding efficacy and cost-effectiveness of telemedicine in rheumatology, areas of uncertainty persist regarding the use of telemedicine in the specialty. More outcomes-based research regarding results of remote care, best use of less frequent in-person visits, and validation of remote disease activity monitoring are needed. 

The value for patients, in terms of preserving access and continuity of care, are undeniable. Telemedicine’s potential benefits, both during and after the COVID-19 pandemic, necessitate careful evaluation and investment for its success. Future reforms should include consideration for all the ACR’s positions. 

The full statement is available at


The American College of Rheumatology (ACR) is an international medical society representing over 8,500 rheumatologists and rheumatology health professionals with a mission to empower rheumatology professionals to excel in their specialty. In doing so, the ACR offers education, research, advocacy and practice management support to help its members continue their innovative work and provide quality patient care. Rheumatologists are experts in the diagnosis, management and treatment of more than 100 different types of arthritis and rheumatic diseases.

Filters close

Showing results

110 of 5429
Released: 16-Apr-2021 4:10 PM EDT
Rutgers Expert Addresses Questions on COVID-19 Vaccine Rollout and Variant Issues
Rutgers University-New Brunswick

Stanley H. Weiss, an epidemiologist in infectious and chronic diseases, and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health, talks about vaccine side effects, the hesitancy that still exists and why it is important to get vaccinated when it’s your turn.

Released: 16-Apr-2021 3:15 PM EDT
Studies suggest people with blood cancers may not be optimally protected after COVID-19 vaccination
American Society of Hematology (ASH)

Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer.

Newswise: Simulations reveal how dominant SARS-CoV-2 strain binds to host, succumbs to antibodies
Released: 16-Apr-2021 2:35 PM EDT
Simulations reveal how dominant SARS-CoV-2 strain binds to host, succumbs to antibodies
Los Alamos National Laboratory

Large-scale supercomputer simulations at the atomic level show that the dominant G form variant of the COVID-19-causing virus is more infectious partly because of its greater ability to readily bind to its target host receptor in the body, compared to other variants.

Newswise: 262279_web.jpg
Released: 16-Apr-2021 2:15 PM EDT
Experimental antiviral for COVID-19 effective in hamster study
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.

Newswise:Video Embedded forum-tackles-vaccine-hesitancy-in-the-black-community
Released: 16-Apr-2021 1:25 PM EDT
Forum Tackles Vaccine Hesitancy in the Black Community

Leading healthcare and faith leaders addressed key issues that are contributing to vaccine hesitancy in Black communities during a national online discussion this week, explaining that a lack of access to healthcare, concerns over vaccine safety, and religious beliefs are keeping many from getting COVID-19 vaccines.

Newswise: COVID-19: Scientists identify human genes that fight infection
Released: 16-Apr-2021 1:10 PM EDT
COVID-19: Scientists identify human genes that fight infection
Sanford Burnham Prebys Medical Discovery Institute

Scientists at Sanford Burnham Prebys have identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. Knowing which genes help control viral infection can greatly assist researchers’ understanding of factors that affect disease severity and also suggest possible therapeutic options. The genes in question are related to interferons, the body’s frontline virus fighters.

Newswise: Study of More Than 3,000 Members of the US Marine Corps. Reveals Past COVID-19 Infection Does Not Fully Protect Young People Against Reinfection
Released: 16-Apr-2021 11:35 AM EDT
Study of More Than 3,000 Members of the US Marine Corps. Reveals Past COVID-19 Infection Does Not Fully Protect Young People Against Reinfection
Mount Sinai Health System

Although antibodies induced by SARS-CoV-2 infection are largely protective, they do not completely protect against reinfection in young people, as evidenced through a longitudinal, prospective study of more than 3,000 young, healthy members of the US Marines Corps conducted by researchers at the Icahn School of Medicine at Mount Sinai and the Naval Medical Research Center, published April 15 in The Lancet Respiratory Medicine.

Released: 15-Apr-2021 8:45 PM EDT
Beyond Boundaries: R Adams Cowley Shock Trauma Center Celebrates Heroes
University of Maryland Medical Center

More than 65 first responders and top trauma medicine professionals who saved the lives of two critically ill patients were honored tonight at the 31st annual R Adams Cowley Shock Trauma Celebration of Heroes. Funds raised by the virtual event will support the Center for Critical Care and Trauma Education.

Released: 15-Apr-2021 4:10 PM EDT
Penn Study Suggests Those Who Had COVID-19 May Only Need One Vaccine Dose
Perelman School of Medicine at the University of Pennsylvania

New findings from Penn suggest that people who have recovered from COVID-19 may only need a single mRNA vaccine dose. However, those who did not have COVID-19 did not have a full immune response until after a second vaccine dose, reinforcing the importance of completing the two recommended doses.

Showing results

110 of 5429